Rafał Dziadziuszko

机构：University of Gdańsk, Gdańsk Medical University · ORCID：0000-0001-8080-9843

发表论文 607 篇 · 总被引 19220 次 · h-index 61

代表论文

• Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study (2025 · Journal of Clinical Oncology · 被引 50)
• Single-Agent Divarasib in Patients With KRAS G12C –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study (2025 · Journal of Clinical Oncology · 被引 27)
• Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study (2025 · Annals of Oncology · 被引 20)
• Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial (2025 · Lung Cancer · 被引 14)
• The KRAS G12C inhibitor MK-1084 for KRAS G12C–mutated advanced colorectal cancer (CRC): Results from KANDLELIT-001. (2025 · Journal of Clinical Oncology · 被引 10)
• LBA69 SKYSCRAPER-03: Phase III, open-label, randomised study of atezolizumab (atezo) + tiragolumab (tira) vs durvalumab (durva) in locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) after platinum-based concurrent chemoradiation (cCRT) (2025 · Annals of Oncology · 被引 7)